Stockreport

AnaptysBio fails in mid-stage study for Imsidolimab in skin disease [Seeking Alpha]

AnaptysBio, Inc.  (ANAB) 
Last anaptysbio, inc. earnings: 3/2 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com/investor-relations
PDF AnaptysBio fails in mid-stage study for Imsidolimab in skin disease [Read more]